Direct Anterior Total Hip Arthroplasty (THA), in Versus Outpatients : A Prospective Monocentric Study in Rennes University Hospital.

NCT ID: NCT03667339

Last Updated: 2023-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-27

Study Completion Date

2018-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to show that cumulative length of stay over the first 45 post operative days (i.e. : primary length of stay and readmission) is significantly lower in the outpatients group than in the inpatients group

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Direct Anterior Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

outpatients group

Patient schedulded to undergo outpatient Direct Anterior Total Hip Arthroplasty

Direct Anterior Total Hip Arthroplasty

Intervention Type PROCEDURE

Direct Anterior Total Hip Arthroplasty

inpatients group

Patient schedulded to undergo inpatient Direct Anterior Total Hip Arthroplasty

Direct Anterior Total Hip Arthroplasty

Intervention Type PROCEDURE

Direct Anterior Total Hip Arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Direct Anterior Total Hip Arthroplasty

Direct Anterior Total Hip Arthroplasty

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral primary total hip arthroplasty for hip osteoarthritis, primary or secondary osteoarthritis (dysplasia or post-traumatic) or osteonecrosis
* Good enough understanding of outpatient management and patient adherence to post-operative instructions
* Sufficient patient complicance to medical orders
* Living and hygiene conditions, at least, equivalent to the ones the hospital provides
* To be of age
* Non opposition to the protocole participation

Outpatients group :

\- Patient schedulded to undergo outpatient THA

Inpatients group :

\- Patient schedulded to undergo inpatient THA because of not fiting the following items :

* Less than an hour distance of a Health Center that provides appropriate care with regard to the surgery
* Rapid access to a phone
* Designated driver and caretaker available (at least the first night after discharge from the hospital) after the procedure Or turning down outpatient THA

Exclusion Criteria

* Anaesthetic point of view :

* ASA physical status ≥ 3 and : unstabilize disease with appropriate treatment or lack of preoperative mutual agreement between anesthesiologist and surgeon or not inconsiderable interaction between the operation and the disease or its treatment
* Pre-operative Hb \< 12 (♀) \< 13 (♂) g/L (NB : no Hb control before discharge except if excessive blood loss ; Hb \< 10g/L contraindicates outpatient surgery)
* Opioid chronic pre-operative therapy or opioid addiction
* Surgical point of view :

* Ambulatory pre-operative status requiring use of two crutches or walking frame / distance walked \< 30 m
* THA procedure for femoral neck fracture requiring
* Additional operative technic needed
* Adult safeguarding.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean Louis POLARD, MD

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Rennes

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

35RC17_3084_AHVACA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.